Marginal zone lymphoma with anti-factor H IgM and atypical hemolytic uremic syndrome successfully treated with odronextamab.
作者信息
Ardissino Gianluigi, Angelillo Piera, Mancuso Maria Cristina, Griffini Samantha, Grovetti Elena, Porcaro Luigi, Ria Thomas, Marktel Sarah, Peyvandi Flora, Luminari Stefano, Ferreri Andrés J M, Merli Michele, Cugno Massimo
机构信息
Centro per la Cura e lo Studio della Sindrome Emolitico-Uremica, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano.
Lymphoma Unit, IRCCS San Raffaele Scientific Institute, Milan.
出版信息
Haematologica. 2025 Sep 1;110(9):2235-2239. doi: 10.3324/haematol.2025.287532. Epub 2025 May 15.
Abstract
摘要
相似文献
1
Marginal zone lymphoma with anti-factor H IgM and atypical hemolytic uremic syndrome successfully treated with odronextamab.
Haematologica. 2025 Sep 1;110(9):2235-2239. doi: 10.3324/haematol.2025.287532. Epub 2025 May 15.
3
Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20×CD3 bispecific antibody, in patients with relapsed/refractory B-cell non-Hodgkin lymphoma.
J Immunother Cancer. 2024 Mar 21;12(3):e008338. doi: 10.1136/jitc-2023-008338.
4
IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome.
J Am Soc Nephrol. 2021 May 3;32(5):1227-1235. doi: 10.1681/ASN.2020081224. Epub 2021 Mar 12.
5
Comprehensive genetic analysis and genotype-phenotype correlations in pediatric patients with atypical hemolytic uremic syndrome.
Pediatr Nephrol. 2025 Jun 6. doi: 10.1007/s00467-025-06814-1.
6
Indirect comparison of epcoritamab vs chemoimmunotherapy, mosunetuzumab, or odronextamab in follicular lymphoma.
Blood Adv. 2025 Aug 12;9(15):3754-3765. doi: 10.1182/bloodadvances.2024015274.
7
A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome/complement-mediated thrombotic microangiopathy.
Kidney Int. 2024 May;105(5):960-970. doi: 10.1016/j.kint.2023.12.021. Epub 2024 Feb 24.
8
Use of complement C5-inhibitor eculizumab in patients with infection-associated hemolytic uremic syndrome - a case-series report.
BMC Pediatr. 2025 Mar 11;25(1):181. doi: 10.1186/s12887-025-05546-3.
9
Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab.
Exp Hematol Oncol. 2017 Jan 13;6:4. doi: 10.1186/s40164-017-0064-7. eCollection 2017.
10
Approach to the prevention of atypical hemolytic uremic syndrome recurrence using eculizumab in a pregnant kidney transplant recipient with complement factor H gene mutation: a case report and literature review.
J Nephrol. 2025 Jul 11. doi: 10.1007/s40620-025-02342-1.
本文引用的文献
1
Cutting-edge approaches to B-cell depletion in autoimmune diseases.
Front Immunol. 2024 Oct 9;15:1454747. doi: 10.3389/fimmu.2024.1454747. eCollection 2024.
2
BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease.
N Engl J Med. 2024 Sep 5;391(9):867-869. doi: 10.1056/NEJMc2408786.
3
CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up.
N Engl J Med. 2024 Feb 22;390(8):687-700. doi: 10.1056/NEJMoa2308917.
5
Complement activation and renal dysfunction in patients with acquired thrombotic thrombocytopenic purpura.
Blood. 2023 May 4;141(18):2278-2282. doi: 10.1182/blood.2022018644.
6
Eculizumab treatment in atypical hemolytic uremic syndrome: correlation between functional complement tests and drug levels.
J Nephrol. 2022 May;35(4):1205-1211. doi: 10.1007/s40620-021-01187-8. Epub 2022 Jan 11.
7
IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome.
J Am Soc Nephrol. 2021 May 3;32(5):1227-1235. doi: 10.1681/ASN.2020081224. Epub 2021 Mar 12.
8
The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance.
Blood. 2016 Apr 28;127(17):2082-92. doi: 10.1182/blood-2015-12-624304. Epub 2016 Mar 17.
9
Discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome: a report of 10 cases.
Am J Kidney Dis. 2014 Oct;64(4):633-7. doi: 10.1053/j.ajkd.2014.01.434. Epub 2014 Mar 19.
10
Anti-factor H autoantibody-associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS.
Semin Thromb Hemost. 2010 Sep;36(6):633-40. doi: 10.1055/s-0030-1262885. Epub 2010 Sep 23.
Zotero 插件